HOME >> MEDICINE >> NEWS
Less Toxic Bone Marrow Transplant Technique May Have More Powerful Anti-Cancer Effect

A research team from the Massachusetts General Hospital (MGH) has shown that it is possible to transplant bone marrow successfully from mismatched human donors without the usual pre-transplant destruction of the patient's own bone marrow. The report appears in the May 22 issue of The Lancet.

The scientists from the hospital's Bone Marrow Transplant Program and Transplantation Biology Research Center (TBRC) successfully induced a state of mixed chimerism - in which the immune systems from both donor and recipient are blended - in four patients with aggressive non-Hodgkins lymphomas that resisted other treatment methods. Two of those patients have achieved long-term remission without significant graft-versus-host disease, a dangerous complication of bone marrow transplantation.

"This proof-of-principal study has shown that we can achieve a lasting combination of donor and recipient immune systems without the kind of toxic treatment usually used to wipe out the recipient's bone marrow," says Megan Sykes, M.D., of the TBRC, the paper's lead author. "We are intrigued by the powerful anti-tumor effect observed in several patients."

Thomas Spitzer, M.D., director of the Bone Marrow Transplant Program and principal investigator of the study described in the Lancet paper, adds, "While it's much too early to say whether this approach will benefit and be safe for all patients with advanced blood-cell cancers, we're very encouraged by the results we've seen."

In standard bone marrow transplantation, patients undergo a pre-transplant process called ablation in which their diseased bone marrow is destroyed by either intense radiation or chemotherapy, essentially wiping out their immune system. Depending on the patient's particular illness, replacement marrow may come from a donor or may be the patient's own marrow treated to remove any malignant cells (an autologous transplant). In the case of treatment-resistant non-Hodgkins lymphoma, a blood-cell canc
'"/>

Contact: Susan McGreevey
smcgreevey@partners.org
617 724-2764
Massachusetts General Hospital
21-May-1999


Page: 1 2 3

Related medicine news :

1. 2005 Pharmacology, Therapeutics, & Toxicology Research Award
2. 2004 Pharmacology/Therapeutics/Toxicology Award to Haas
3. BioNumerik Reports The Supercomputer Supported Discovery Of New, Non-Toxic Chemotherapy Protecting Agent
4. Marrow injection gets damaged hearts moving
5. Organ Transplants Helped By Donor Bone Marrow, University Of Pittsburgh Researchers Report At National Transplant Meetings
6. Bone Marrow With Heart And Lung Transplants Reduces Rejection Of Transplanted Organs, Reports University Of Pittsburgh
7. Bone Marrow With Organ Transplants Reduces Rejection Of Transplanted Organs, Reports University Of Pittsburgh
8. Duke Researchers Identify New Pulmonary Syndrome Associated With Bone Marrow Transplantation For Breast Cancer
9. Transplanted bone marrow cells reduce liver fibrosis in mice
10. Transplant of pig tissue may reduce stroke size and damage
11. Roche pledges continued support for Organ Transplantation Research Foundation

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one ... an innovative new design of the shoulder pad. The shoulder pad provides optimal ... controlling your pain while using cold therapy. By utilizing ice and water that is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... (HLA), the nation's first interactive health literacy software tool, and the Cancer Patient ... aspects of cancer patient education, today announce a new strategic alliance. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... University of California Berkeley, and other leading institutions in announcing the launch of ... institutions to change the way animals are raised for food. , Founding members ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... Centers for Disease Control and Prevention (CDC), influenza vaccination should take ... communities across Massachusetts , Connecticut , ... through the end of the month. *Some exclusions apply ... ... by the end of October, according to the Centers for Disease Control ...
(Date:10/2/2017)...  AllianceRx Walgreens Prime, the combined central specialty pharmacy ... benefit manager Prime Therapeutics LLC (Prime), today officially began ... unveiling of new signage at its headquarters in ... a few other company-owned facilities across the country. This ... of whom will begin to see the AllianceRx Walgreens ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
Breaking Medicine Technology:
Cached News: